Malin Corporation | MLC - Ativo Circulante





Ativo Circulante Alterar Data
Akebia Therapeutics USD 243.48M 9.47M 2026-03
Alaunos Therapeutics USD 970K 1.02M 2026-03
ALKERMES USD 1.36B 570.52M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Eurofins Scientific SE EUR 2.65B 34.2M 2025-12
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
IQVIA Holdings USD 6.22B 29M 2026-03
Lonza CHF 8B 3.41B 2025-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Moderna USD 5.77B 774M 2026-03
Organon & Co USD 4.93B 580M 2026-03
Ovoca Bio EUR 1.56M 3.39M 2025-06
Revvity USD 2.13B 111.43M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Viatris USD 10.92B 1.13B 2026-03
Xeris Pharmaceuticals USD 251.68M 11.37M 2026-03